Assessment of liver function tests in pregnant women at a tertiary care center
DOI:
https://doi.org/10.61841/nnxjsw86Keywords:
Liver physiology, liver function, pregnantAbstract
Assessment of liver function tests in pregnant women at a tertiary care center
Dr. Kanwaljeet Kaur
Assistant Professor, Department of Pathology, Sri Guru Ram Das Institute of Medical Sciences & Research, Amritsar, Punjab
ABSTRACT
Background: Liver physiology may change during pregnancy, which later on may progress to liver disease. The severity of the disease is related to morbidity and mortality. The present study was conducted to assess liver function tests (LFT) in pregnant women at a tertiary care center.
Materials & Methods: 74 pregnant women with abnormal LFT were carefully examined. Symptoms were recorded. The definition of abnormal LFT pertained to values higher than the normal range as defined by the local laboratory (bilirubin >24mol/L, alkaline phosphatase (ALP) >103 U/L, gamma-glutamyltranspeptidase (GGT)>26 U/L, ALT >51 U/L, aspartate aminotransferase (AST)>33 U/L).
Results: In 1st trimester causes of abnormal LFT was hyperemesis gravidarum in 36, typhoid in 4. In 2nd trimester, hyperemesis gravidarum in 5 and choledocholisthesis in 3. In 3rd trimester, acute fatty liver of pregnancy in 6, drug induced in 4, HELLP syndrome in 1, hepatitis B flare in 3, intrahepatic cholestasis of pregnancy in 3, PET in 2, partial HELLP syndrome in 3 and unknown in 4 cases. The difference was significant (P< 0.05). LFT in Hyperemesis Gravidarum, PET and partial HELLP Syndrome such as total bilirubin (µmol/L) was 22.5, 14.6 and 15.4, in ALP (U/L) was 53.5, 201.5 and 192.1, in GGT (U/L) was 43.8, 17.3 and 35.8, in ALT (U/L) was 101.5, 112.8 and 143.6, in AST (U/L) was 74.2, 64.2 and 83.7 and albumin (g/L) was 35.3, 29.5 and 32.5 respectively. The difference was significant (P< 0.05).
Conclusion: Anxiety can be reduced and proper obstetric planning for the delivery date can be made possible by being aware of the probable causes of an abnormal LFT at different stages of pregnancy. Given the possibility of a more severe seroconversion reaction in the immediate postpartum period, more care should be used when evaluating an obstetric patient's abnormal LFT if they have HBsAg.
Downloads
References
References
1. Conchillo JM, Koek GH. Hyperemesis gravidarum and severe liver enzyme elevation. J Hepatol 2002;37:162-6.
2. Saphier CJ, Repke JT. Haemolysis, Elevated Liver Enzymes, and Low Platelets (HELLP) Syndrome: A review of diagnosis and management. Semin Perinatol 1998;22:118-33.
3. Zakim D, Boyer TD, editors. Hepatology: A Textbook of Liver Disease. Philadelphia: WB Saunders Co, 1996.
4. Wilkie G, Schutz E, Armstrong VW, Kuhn W. Haptoglobin as a sensitive marker of haemolysis in HELLP syndrome. Int J Gynecol Obstet 1992;39:29-34.
5. Aarnoudse JG, Houthoff HJ, Weits J, Vellenga E, Huisjes HJ. A syndrome of liver damage and intravascular coagulation in the last trimester of normotensive pregnancy: a clinical and histopathological study. Br J Obstet Gynaecol 1986;93:145-55.
6. Crawford JM. The liver and the biliary tree. In: Cotrans RS, Kumar V, Robbins, editors. Robbins Pathologic Basis of Disease. 5th ed. Philadelphia: WB Saunders, 1994:875.
7. Audibert F, Friedman SA, Frangich AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (haemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460-4.
8. Minakami H, Oka N, Sato T, Tamada T, Yasuda Y, Hirota N. Preeclampsia: a microvesicular fat disease of the liver? Am J Obstet Gynecol 1988;159:1043-7.
9. Lin HH, Chen PJ, Chen DS, Sung JL, Yang KH, Young YC, et al. Postpartum subsidence of hepatitis B viral replication in HBeAg- positive carrier mothers. J Med Virol 1989;29:1-6.
10. Hidaka Y, Amino N, Iwatani Y, Kaneda T, Matsuda N, Morimoto Y, et al. Changes in natural killer cell activity in normal pregnant and post- partum women: increases in the first and second post-partum period and decrease in late pregnancy. J Reprod Immunol 1991;20:73-83.
11. Carr BR, Parker CR Jr, Madden JD, MacDonald PC, Porter JC. Maternal plasma adenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol 1981;139:416-22.
12. Fontaine H, Nalpas B, Carnot C, Brechot C, Pol S. Effect of pregnancy on chronic hepatitis C: a case-control study. Lancet 2000;356:1328-9.
13. Steven MM, Buckley J, Mackay I. Pregnancy in chronic active hepatitis. Q J Med 1979;48:519-31.
14. Wong HY, Tan JY, Lim CC. Abnormal liver function tests in the symptomatic pregnant patient: the local experience in Singapore. Annals-academy of medicine singapore. 2004 Mar 1;33(2):204-8.
15. Wallstedt A, Riely CA, Shaver D, Leventhal S, Adamec TA, Nunnally J, et al. Prevalence and characteristics of liver dysfunction in hyperemesis gravidarum. Clin Res 1990;38:970.
16. Jarnfelt-Samsioe A, Eriksson B, Waldenstrom J, Samsioe G. Serum bile acids, gamma-glutamyltransferase and routine liver function tests in emetic and nonemetic pregnancies. Gynecol Obstet Invest 1986;21:169–176
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
